[{"Assets_0_Q1_USD":"129285000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.45","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.34","EarningsPerShareDiluted_1_Q1_USD":"-0.34","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","MinorityInterest_0_Q1_USD":"66000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"3894000000.0","NetIncomeLoss_1_Q1_USD":"-775000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","PaymentsOfDividends_1_Q1_USD":"1017000000.0","ProfitLoss_1_Q1_USD":"-766000000.0","RevenuesConverted_1_Q1_USD":"10781000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"49977000000.0","StockholdersEquity_0_Q1_USD":"49911000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"2258000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"2258000000.0","filed":"20200507","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"BRISTOL MYERS SQUIBB CO","period":"20200331","qtrs":"0","uom":"USD"}]